Type 1 diabetes

Evaluation of the Steno Type 1 Risk Engine in predicting cardiovascular events in an ethnic mixed population of type 1 diabetes mellitus and its association with chronic microangiopathy complications

Cardiovasc DiabetolPublished Retrospective cohort study

Authors' conclusion

ST1RE performed well in predicting CV events at 5 and 10 years of follow-up. Moreover, higher ST1RE scores were associated with the progression of microangiopathy complications in this genetically heterogeneous T1D population.

Study context

Population
Adults with T1D free of cardiovascular (CV) events at baseline, ethnically mixed population; median age 25 years (IQR 21–32), median T1D duration 13 years (IQR 9–18)
Participants
435 adults
Exposure
High and moderate vs low ST1RE risk groups
Outcome
Performance of ST1RE in predicting CV events
Follow-up
5 and 10 years
Methodological detailsprognostic model validation
  • Prognostic model validation

Main finding

As reported in the abstract

CV events · median follow-up 9.2 years (IQR 6.0-10.7)
Hazard ratio (95% CI)P value
Highvs Low
52.02(18.60–145.51)
P < 0.001
Moderatevs Low
8.66(2.90–25.80)
P < 0.001
Overall patients with a CV event
5.5%
Estimated vs observed CV events at 5 years
3.4% vs. 3.5%; χ2 = 10.12, p = 0.899
Estimated vs observed CV events at 10 years
6.8% vs. 9.9%; χ2 = 14.80, p = 0.676

Observational data: associations, not effects.

Further findings

OutcomeP value
Progression of microangiopathies, high vs low ST1REHigh vs Low · greater with HighP = 0.008
Progression of microangiopathies, high vs low ST1REHigh vs Low · greater with HighP < 0.001
Progression of microangiopathies, high vs low ST1REHigh vs Low · greater with HighP = 0.021
Progression of microangiopathies, high vs low ST1REHigh vs Low · greater with HighP = 0.008

Original publication

Evaluation of the Steno Type 1 Risk Engine in predicting cardiovascular events in an ethnic mixed population of type 1 diabetes mellitus and its association with chronic microangiopathy complications. Cardiovasc Diabetol. Published 22 October 2024. doi:10.1186/s12933-024-02460-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.